Gold Flora Valuation

Q: What is the Fair Price of GRAM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

GRAM ($0.05) is trading below our estimate of [[fair value]] ($6.12)

Is GRAM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GRAM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GRAM ($0.05) is trading below our estimate of fair value ($6.12)

Significantly Below Fair Value: GRAM is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GRAM?

Key metric: As GRAM is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GRAM. This is calculated by dividing GRAM's market cap by their current revenue.
What is GRAM's PS Ratio?
PS Ratio	0.1x
Sales	US$124.81m
Market Cap	US$10.99m

GRAM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.3x
Enterprise Value/EBITDA	-14.7x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does GRAM's PS Ratio compare to its peers?

The above table shows the PS ratio for GRAM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.6x
INBP Integrated BioPharma	0.2x	n/a	US$9.8m
MTEX Mannatech	0.1x	n/a	US$15.8m
LIFD LFTD Partners	0.2x	n/a	US$8.9m
DQWS DSwiss	6x	n/a	US$15.1m
GRAM Gold Flora	0.1x	21.4%	US$11.0m

Price-To-Sales vs Peers: GRAM is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1.6x).

Price to Sales Ratio vs Industry

How does GRAM's PS Ratio compare vs other companies in the US Personal Products Industry?

26 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	1.0x	4.7%
GRAM Gold Flora	0.1x	21.4%	US$10.99m
HLF Herbalife	0.2x	1.8%	US$856.73m
NUS Nu Skin Enterprises	0.2x	-0.06%	US$362.89m

26 Companies		Estimated Growth	Market Cap
Industry Avg.	1.0x	26.0%
GRAM Gold Flora	0.1x	n/a	US$10.99m

No more companies

Price-To-Sales vs Industry: GRAM is good value based on its Price-To-Sales Ratio (0.1x) compared to the US Personal Products industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is GRAM's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GRAM PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.1x
Fair PS Ratio	1.2x

Price-To-Sales vs Fair Ratio: GRAM is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (1.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Beauty Health

US$184.9m

Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

SKIN

US$1.39

-22.3%

-37.5%

Kimberly-Clark de México S. A. B. de C. V

Mex$86.0b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.F

Mex$1.37

-5.8%

n/a

Reynolds Consumer Products

US$5.8b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.61

-0.5%

6.2%